We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Delivery

Article   Jul 23, 2019 | by Laura Elizabeth Lansdowne, Science Writer, Technology Networks

 
Drug Delivery
 
 
 

RELATED ARTICLES

Therapeutic Gene Editing for Sickle Cell Disease

Article

Sickle cell disease is the most common inherited blood disorder in the US, affecting > 70,000 Americans. Christopher Vakulskas, Senior Staff Scientist, Integrated DNA Technologies discusses efforts to develop a sickle cell disease therapy using CRISPR gene editing.

READ MORE

Why Science Can’t Afford Mistakes When It Comes to Cell Line Authenticity

Article

Having strains and cell lines that have been checked and confirmed to be what it says on the tube is invaluable to scientific validity and integrity, saving untold time and money. We spoke to Mindy Goldsborough, Ph.D., Chief Science and Technology Officer, VP and General Manager, ATCC Cell Systems about the importance and challenges of maintaining authenticated cell lines for scientific research.

READ MORE

"MOSAIC" HIV Vaccine to be Tested in Thousands Globally

Article

A clinical trial testing a "mosaic" HIV vaccine is due to commence in September. The trial is pertinent considering a recent UNAIDS report expressed concerns that the pace of progress in reducing new HIV infections has slowed. This article discusses the plans for the trial and the current status of vaccine research in the field.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE